Launch of Xenios console & Novalung patient kits in South Korea

5. November 2021

Happy to share some great news!

Fresenius Medical Care announced the launch of the Xenios console and Novalung patient kits in South Korea!

The introduction of heart and lung therapies expands Fresenius Medical Care’s portfolio in South Korea to multi-organ support. The Xenios console was approved by the Ministry of Food and Drug Safety (MFDS) in May, 2021, following the approval of the Novalung patient kits in November 2020.

Read original press release in Korean language: http://ow.ly/1jwa50GG2gv

Back to News

EACTS Annual Meeting 2024

22. October 2024

Thank You, EACTS Annual Meeting 2024! Grateful to the organizers, speakers, and everyone who made this event a success. It was an inspiring time of innovation, insights, and great connections. Looking forward to applying what we’ve learned and staying in touch!

Fresenius Medical Care is taking the next step in extracorporeal life support with Xenios 2.0

15. October 2024

Fresenius Medical Care’s heart & lung business unit, Xenios AG, introduces the all-new Xenios 2.0. This system enables healthcare professionals to take the next step in extracorporeal life support (ECLS). It can be used for the full range of ECLS treatments, from neonatal to adult patients, and is approved ...

ESICM LIVES congress 2024

Thank You, ESICM LIVES 2024! What an incredible 37th Annual ESICM LIVES Congress in Barcelona! A huge thank you to the organizers, speakers, and participants for delivering an inspiring and informative event. Looking forward to implementing the takeaways and staying connected with the brilliant minds we met during the congress. Until ...